Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tooth demineralization is the loss of mineral ions—primarily calcium and phosphate—from the hydroxyapatite structure of tooth enamel and dentin, frequently driven by acidic conditions created by bacterial metabolism of dietary carbohydrates or by direct exposure to dietary/intrinsic acids. This process lowers local pH, dissolves mineral content, and leads to early caries lesions (white spots) or advanced tissue breakdown (cavities), particularly when remineralization processes do not compensate for mineral loss. Demineralization is a dynamic, reversible process when the oral environment favors remineralization, such as with adequate saliva, controlled dietary sugars, and use of remineralizing agents like fluoride, but is ultimately a *process*, not a unified molecular pharmacological target.
Agents decrease demineralization and/or promote remineralization (e.g., fluoride incorporates into enamel as fluorapatite, increasing resistance to acid dissolution)\nElevation of oral pH or enhancement of mineral ion saturation at the tooth surface
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tooth demineralization (null).